New combo therapy aims to knock out hepatitis c virus
NCT ID NCT01753570
Summary
This study tested whether a three-drug combination (MP-424, interferon beta, and ribavirin) could successfully control Hepatitis C virus in people with specific strains of the disease. It involved 74 patients who were either new to treatment or had tried previous interferon-based therapy. The main goal was to see if the virus remained undetectable in the blood six months after finishing the treatment course.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS C (CHC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toranomon Hospital
Kawasaki, Takatsu-ku, 213-8587, Japan
Conditions
Explore the condition pages connected to this study.